Arcus Biosciences Inc.

RCUS | NYSE

Price Alert Chart Builder DCF Calculator

$26.61

+$0.66 (+2.54%)

Sep 22, 2026, 11:25 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	222M	150M	127M	206M	147.91M	173.42M
Short-Term Investments	759M	828M	632M	803M	351.39M	555.23M
Long-Term Investments	29M	14M	107M	134M	185M	6.64M
Other Long-Term Assets	63M	73M	106M	10M	7.73M	6.25M
Receivables	16M	25M	42M	43M	746.82M	1.7M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	10M	13M	30M	14M	14.72M	4.47M
Total Current Assets	1.01B	1.02B	831M	1.07B	1.26B	735.82M
Property-Plant & Equipment	40M	47M	51M	135M	137.42M	23.59M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	132M	134M	264M	279M	330.15M	36.48M
Total Assets	1.14B	1.15B	1.1B	1.35B	1.59B	772.29M
Account Payables	42M	18M	17M	20M	10.26M	15.68M
Deferred Revenue	35M	85M	91M	97M	102M	74.57M
Short-Term Debt	n/a	n/a	n/a	3M	5.1M	2.87M
Other Current Liabilities	18M	14M	39M	48M	30.26M	19.92M
Total Current Liabilities	231M	226M	184M	193M	166.08M	121.67M
Long-Term Debt	99M	48M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	135M	157M	142M	23M	5.26M	10.25M
Total Long-Term Liabilities	277M	439M	449M	495M	584.36M	148.32M
Total Liabilities	508M	665M	633M	688M	750.45M	269.99M
Total Debt	112M	60M	11M	120M	121.99M	18.11M
Book Value	631M	485M	462M	657M	841.45M	502.3M
Book Value Per Share	5.88	5.38	6.24	9.13	11.38	9.17
Common Stock	2.12B	1.62B	1.31B	1.21B	7K	6K
Retained Earnings	-1.49B	-1.13B	-849M	-542M	-275.35M	-328.18M
Comprehensive Income	n/a	n/a	n/a	-7M	-1.26M	44K
Shareholders Equity	631M	485M	462M	657M	841.45M	502.3M
Total Investments	788M	842M	739M	937M	536.39M	561.87M